Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome

ClinicalTrials.gov ID: NCT01237587

Public ClinicalTrials.gov record NCT01237587. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 1:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect of Duloxetine 30/60 mg Once Daily Versus Placebo in Adolescents With Juvenile Primary Fibromyalgia Syndrome

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether duloxetine is safe and effective in the treatment of adolescents with Juvenile Primary Fibromyalgia Syndrome (JPFS). This trial consists of two distinct study periods. A blinded treatment period of 13 weeks and an open label extension period of 26 weeks.

Study identification

NCT ID
NCT01237587
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
184 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
13 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
May 30, 2017
Completion
Nov 27, 2017
Last update posted
Sep 19, 2019

2011 – 2017

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
NoesisPharma Phoenix Arizona 85032
Loma Linda University School of Medicine Loma Linda California 92354
Synergy Clinical Research National City California 91950
Connecticut Clinical Trials LLC Cromwell Connecticut 06416
Associated Neurologists of Southern Connecticut Fairfield Connecticut 06824
Palm Beach Research Center West Palm Beach Florida 33409
Institute for Behavioral Medicine Smyrna Georgia 30080
Riley Hosptial for Children Indianapolis Indiana 46202
Kentucky Medical Research Center Lexington Kentucky 40504
Mercy Health Research St Louis Missouri 63141
Healthy Perspectives Innovative Mental Health Services, PL Nashua New Hampshire 03060
Albuquerque Neurosciences Albuquerque New Mexico 87109
Bioscience Research, LLC Mount Kisco New York 10549
Richmond Behavorial Associates Staten Island New York 10312
Neurobehavioral Clinical Research Canton Ohio 44718
Univ of Cincinnati College of Medicine Cincinnati Ohio 45219
North Star Research Middleburg Heights Ohio 44130
Neuropsychiatric Center Oklahoma City Oklahoma 73109
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
CRI Lifetree Philadelphia Pennsylvania 19139
Holston Medical Group Clinical Research Kingsport Tennessee 37660
Arthritis and Osteoporosis Center of South Texas San Antonio Texas 78232
Bateman Horne Center of Excellence Salt Lake City Utah 84102
NeuroScience, Inc. Herndon Virginia 20170-2613
Advanced Pain Management Virginia Beach Virginia 23505
Northwest Clinical Research Center Bellevue Washington 98007-4209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01237587, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 19, 2019 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01237587 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →